Helix BioMedix's Drug Development Program focuses on unmet needs in the rare dermatological disease market. Additionally, the Company has a … Read more... about Programs

Helix BioMedix, Inc. has created an extensive proprietary library of bioactive peptides based upon … Continue Reading…
Helix BioMedix, Inc. has an extensive library of diverse bioactive peptides and patents covering a … Continue Reading…
Helix BioMedix’s Drug Development Program focuses on unmet needs in the rare dermatological disease … Continue Reading…
Helix BioMedix's Drug Development Program focuses on unmet needs in the rare dermatological disease market. Additionally, the Company has a … Read more... about Programs
Helix BioMedix, Inc., is committed to building long term shareholder value through development of novel drugs for rare dermatological … Read more... about Investors
Helix scientists have created a vast library of proprietary peptides initially based upon the diversity of structures, functions and activities of innate immunity peptides.
Find out about our commercially available peptides here.
Helix BioMedix is a leading innovator in peptide discovery and development. Our intellectual property covers an immensely diverse … Read more... about Partners
Helix BioMedix Inc., is an innovator in drug development for treatment of rare dermatological diseases and ancillary skin health. Coming … Read more... about Presentations
Helix BioMedix, Inc. Email Us 22121 17th Avenue SE, Suite 112 Bothell, WA 98021 USA Phone: 425.402.8400 Driving Directions: From South … Read more... about Contact Page
Helix BioMedix is a biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body’s innate immunity.
©2021 HELIX BIOMEDIX, INC.
ALL RIGHTS RESERVED